Tag: COPD

Phase III Trials Show Tozorakimab Reduces COPD Exacerbations with Promising Safety Profile

Phase III trials indicate that tozorakimab effectively reduces COPD exacerbations and shows…

ME Desk

AstraZeneca Reveals New Research on Respiratory & Immune Diseases

May 2024- AstraZeneca will showcase new clinical and real-world data across its…

ME Desk